- Home
- ARKO vs BNTC Comparison
ARKO vs BNTC Comparison
Compare ARKO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARKO
- BNTC
- Stock Information
- Founded
- ARKO 1970
- BNTC 1995
- Country
- ARKO United States
- BNTC United States
- Employees
- ARKO N/A
- BNTC N/A
- Industry
- ARKO Oil Refining/Marketing
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ARKO Energy
- BNTC Health Care
- Exchange
- ARKO Nasdaq
- BNTC Nasdaq
- Market Cap
- ARKO 453.2M
- BNTC 365.1M
- IPO Year
- ARKO N/A
- BNTC N/A
- Fundamental
- Price
- ARKO $4.40
- BNTC $15.70
- Analyst Decision
- ARKO Buy
- BNTC Strong Buy
- Analyst Count
- ARKO 3
- BNTC 5
- Target Price
- ARKO $7.50
- BNTC $24.80
- AVG Volume (30 Days)
- ARKO 410.9K
- BNTC 63.3K
- Earning Date
- ARKO 11-05-2025
- BNTC 11-13-2025
- Dividend Yield
- ARKO 2.68%
- BNTC N/A
- EPS Growth
- ARKO N/A
- BNTC N/A
- EPS
- ARKO 0.08
- BNTC N/A
- Revenue
- ARKO $8,131,937,000.00
- BNTC N/A
- Revenue This Year
- ARKO N/A
- BNTC N/A
- Revenue Next Year
- ARKO N/A
- BNTC N/A
- P/E Ratio
- ARKO $56.02
- BNTC N/A
- Revenue Growth
- ARKO N/A
- BNTC N/A
- 52 Week Low
- ARKO $3.51
- BNTC $9.10
- 52 Week High
- ARKO $7.84
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- ARKO 51.93
- BNTC 59.01
- Support Level
- ARKO $3.94
- BNTC $15.18
- Resistance Level
- ARKO $4.57
- BNTC $16.24
- Average True Range (ATR)
- ARKO 0.15
- BNTC 0.79
- MACD
- ARKO 0.07
- BNTC 0.07
- Stochastic Oscillator
- ARKO 80.23
- BNTC 66.10
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.